Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Mariana A. Lysenko"'
Autor:
Ruslan N. Trushkin, Teymur K. Isaev, Pavel E. Medvedev, Nikolai E. Shcheglov, Valerii V. Variasin, Mariana A. Lysenko, Ilya V. Dmitriev, Aslan G. Balkarov, Laura A. Kesaeva
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-6 (2024)
Abstract Introduction Kidney transplantation is the optimal treatment modality for patients with end-stage chronic kidney disease. The long-term mortality of kidney recipients is 48–82% lower than that of patients on the waiting list. However, the
Externí odkaz:
https://doaj.org/article/c12e8f676f334782adc80ef9689f22d6
Autor:
Daria S. Fomina, Sergey V. Fedosenko, Elena N. Bobrikova, Anton A. Chernov, Olga A. Mukhina, Marina S. Lebedkina, Alexander V. Karaulov, Asel Yu. Nurtazina, Mariana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 95, Iss 7, Pp 568-573 (2023)
Background. Dupilumab, a fully human monoclonal antibody directed against the common -subunit of interleukin (IL)-4 receptors and blocking signaling from both IL-4 and IL-13, may be recommended for the treatment of moderate to severe atopic dermatiti
Externí odkaz:
https://doaj.org/article/65e68e2d00ba4c998efe7da08dfc2317
Autor:
Marina S. Lebedkina, Daria S. Fomina, Zinaida Y. Mutovina, Ulyana A. Mаrkina, Pavel O. Bogomolov, Vladimir P. Chulanov, Mariana A. Lysenko, Ekaterina I. Alexeeva
Publikováno v:
Терапевтический архив, Vol 95, Iss 6, Pp 494-499 (2023)
Aim. To evaluate the efficacy and safety of a combination of virus-neutralizing monoclonal antibodies MAB (casirivimab and imdevimab) in patients with mild to moderate COVID-19 with risk factors in real word settings. Materials and methods. A non-
Externí odkaz:
https://doaj.org/article/eb72a7ef09da4ff099f9522bed183bf7
Autor:
Anna A. Roppelt, Marina S. Lebedkina, Anton A. Chernov, Tatiana S. Kruglova, Olga A. Mukhina, Yulia D. Yukhnovskaya, Farida A. Samedova, Ulyana A. Mаrkina, Gerelma V. Andrenova, Alexander V. Karaulov, Mariana A. Lysenko, Daria S. Fomina
Publikováno v:
Терапевтический архив, Vol 95, Iss 1, Pp 78-84 (2023)
Background. Primary immunodeficiencies (PIDs), now known as inborn errors of immunity, are a group of inherited diseases caused by defects in the genes that control the immune response. Patients with PIDs have risks of developing a severe course and/
Externí odkaz:
https://doaj.org/article/2d43eed5d4bf4eb69941f07a641d44c2
Autor:
Ulyana A. Markina, Daria S. Fomina, Marina S. Lebedkina, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva, Zinaida Yu. Mutovina, Alexander V. Karaulov, Ekaterina I. Alexeeva, Mariana A. Lysenko
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 675-682 (2022)
Background. The use of virus-neutralizing monoclonal antibodies is an effective method of etiotropic therapy for SARS-CoV-2 in patients of high-risk groups of severe COVID-19. Regdanvimab is a single-component monoclonal antibodies immunoglobulin G1,
Externí odkaz:
https://doaj.org/article/1ca7266523cb42cb8962e01de2e8c208
Autor:
Alexey I. Khripun, Andrey V. Starshinin, Yulia O. Antipova, Mariana A. Lysenko, Yulia V. Urozhaeva, Olga F. Gavrilenko, Natalya A. Rusantsova, Andrei A. Tyazhelnikov, Elena Yu. Tikhonovskaya, Natalia V. Okolot, Maria V. Sokolova, Daria S. Fomina, Elena N. Simonova, Tatiana S. Kruglova, Anton A. Chernov, Alena I. Zagrebneva
Publikováno v:
Терапевтический архив, Vol 94, Iss 5, Pp 668-674 (2022)
Aim. To study the effect of levilimab or baricitinib in combination with standard therapy (ST) on the incidence of severe viral pneumonia associated with a new coronavirus infection COVID-19. Materials and methods. A multicenter, open-label observ
Externí odkaz:
https://doaj.org/article/6e1e406685f6453fb14793c3ed915970
Autor:
Elena A. Baryakh, Olga L. Kochneva, Elena N. Misyurina, Evgenia I. Zhelnova, Konstantin V. Yatskov, Alena I. Zagrebneva, Rushan R. Zyangirov, Inna V. Samsonova, Natalia G. Poteshkina, Mariana A. Lysenko, Irina V. Poddubnaya
Publikováno v:
Современная онкология, Vol 22, Iss 2, Pp 74-78 (2020)
Justification. Oncological diseases, along with diabetes, hypertension, cardiovascular and chronic obstructive pulmonary diseases, are associated with severe course and worst prognosis of the new coronavirus infection COVID-19. Due to the limited num
Externí odkaz:
https://doaj.org/article/50904b24199748a6bb5bbcb279ee0fe2
Publikováno v:
Respiratory Medicine Case Reports, Vol 38, Iss , Pp 101676- (2022)
The progression of secondary pulmonary damage in SARS-COV-2 infection, associated with interstitial damage, inflammation and alveolar consolidation and eventually resulted in the development of pulmonary fibrosis (PF), remains one of the key clinical
Externí odkaz:
https://doaj.org/article/0a91236ad4a945319bb3b0cb6c51279b
Autor:
Daria S. Fomina, Olga A. Mukhina, Elena N. Bobrikova, Marina S. Lebedkina, Anton A. Chernov, Mariana A. Lysenko
Publikováno v:
Russian Journal of Allergy. 19:425-434
BACKGROUND: The availability of anti-IgE therapy for allergic rhinitis has actualized the need to develop variants of this treatment according to predictors of rapid response and techniques of treatment initiation. AIM: To study the efficacy and pred
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9109e7be84204174544f6663c9248016
https://doi.org/10.36691/rja1564
https://doi.org/10.36691/rja1564
Autor:
Daria S. Fomina, Natalya P. Maltseva, Sofia A. Serdotetskova, Inna V. Danilycheva, Marina S. Lebedkina, Valeriya I. Mikhaylova, Elena V. Kovalkova, Nikita S. Chikunov, Alexander V. Karaulov, Mariana A. Lysenko
Publikováno v:
Russian Journal of Allergy. 19:317-327
BACKGROUND: Chronic inducible urticaria is a group of diseases that is characterized by the development of wheals, angioedema, or both in response to specific triggers for 6 weeks. According to global scientific international literature, the occurren
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1a72137e22d76b0a82e092a1404094e
https://doi.org/10.36691/rja1573
https://doi.org/10.36691/rja1573